Showing results (1311-1320 of 3,687) with videos related to
Sort By:
Pageof 369
Contemporary Clinical Trials|May 3, 2011
Use of a precious resource: parental decision making about using autologous umbilical cord blood in studies involving young children with type 1 diabetesKimberly A Driscoll, Suzanne Bennett Johnson, Desmond A Schatz, et al.Contemporary Clinical Trials|May 17, 2011
The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trialsJie Zhang, Hong Zhang, Chunhua Yu, et al.Contemporary Clinical Trials|May 24, 2011
Recruiting and retaining family caregivers to a randomized controlled trial on mindfulness-based stress reductionRobin R Whitebird, Mary Jo Kreitzer, Beth A Lewis, et al.Contemporary Clinical Trials|March 9, 2011
Balancing multiple baseline characteristics in randomized clinical trialsZheng SuContemporary Clinical Trials|March 9, 2011
Recruitment of lactating women into a randomized dietary intervention: successful strategies and factors promoting enrollment and retentionNicole R Stendell-Hollis, Monica J Laudermilk, Julie L West, et al.Contemporary Clinical Trials|August 3, 2011
Vasopressors and the search for the optimal trial designRitesh MaharajContemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.Contemporary Clinical Trials|July 19, 2011
The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney diseaseD Fliser, F Dellanna, M Koch, et al.Contemporary Clinical Trials|July 19, 2011
A community randomised controlled trial evaluating a home-based environmental intervention package of improved stoves, solar water disinfection and kitchen sinks in rural Peru: rationale, trial design and baseline findingsS M Hartinger, C F Lanata, J Hattendorf, et al.Contemporary Clinical Trials|June 14, 2011
Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 1: Ethical considerationsGreg Ball, Linda B Piller, Michael H SilvermanPageof 369